Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Fortress Biotech (FBIO) Revenue: 2009-2024

Historic Revenue for Fortress Biotech (FBIO) over the last 16 years, with Dec 2024 value amounting to $57.7 million.

  • Fortress Biotech's Revenue rose 20.52% to $17.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $62.3 million, marking a year-over-year decrease of 0.32%. This contributed to the annual value of $57.7 million for FY2024, which is 31.76% down from last year.
  • Fortress Biotech's Revenue amounted to $57.7 million in FY2024, which was down 31.76% from $84.5 million recorded in FY2023.
  • In the past 5 years, Fortress Biotech's Revenue registered a high of $84.5 million during FY2023, and its lowest value of $45.6 million during FY2020.
  • Its 3-year average for Revenue is $72.6 million, with a median of $75.7 million in 2022.
  • As far as peak fluctuations go, Fortress Biotech's Revenue soared by 50.86% in 2021, and later plummeted by 31.76% in 2024.
  • Fortress Biotech's Revenue (Yearly) stood at $45.6 million in 2020, then soared by 50.86% to $68.8 million in 2021, then increased by 10.11% to $75.7 million in 2022, then increased by 11.58% to $84.5 million in 2023, then crashed by 31.76% to $57.7 million in 2024.